The promise of immunotherapy in head and neck, and prostate cancer
7 Aug 2018
The promise of immunotherapy in head and neck, and prostate cancer
The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer
Key advances in ALL and AML
Four studies about relapsed myeloma and advanced disease
Stephan Kiefer outlines the iManageCancer platform
iManageCancer clinical pilot design and preliminary outcomes
A pilot study for the iManageCancer platform
The 'My Health Avatar' app for iManageCancer
The iManageCancer platform
Preventing ovarian cancer through early excision of tubes and late ovarian removal
Population-wide testing for cancer-associated mutations
The ICMC: a new path for microbiome research